| Capot Chemical Co., Ltd. | China | Inquire | ||
|---|---|---|---|---|
![]() |
+86 (571) 8558-6718 +86 13336195806 | |||
![]() |
capotchem@gmail.com sales@capotchem.com | |||
![]() |
QQ chat | |||
| Chemical manufacturer | ||||
| chemBlink standard supplier since 2006 | ||||
| Alfa Chemistry | USA | Inquire | ||
|---|---|---|---|---|
![]() |
+1 (201) 478-8534 | |||
![]() |
inquiry@alfa-chemistry.com | |||
| Chemical distributor since 2012 | ||||
| chemBlink standard supplier since 2012 | ||||
| Zaozhuang Benefit Chemical Co., Ltd. | China | Inquire | ||
|---|---|---|---|---|
![]() |
+86 (632) 440-3508 | |||
![]() |
sales@benefit-chem.com Benefit-Chem@hotmail.com | |||
| Chemical manufacturer | ||||
| chemBlink standard supplier since 2012 | ||||
| Shandong Huimeng Biotech Co., Ltd. | China | Inquire | ||
|---|---|---|---|---|
![]() |
+86 (530) 884-2888 +86 18523002917 | |||
![]() |
cindy@szgoldenunion.com | |||
| Chemical manufacturer since 2013 | ||||
| chemBlink standard supplier since 2016 | ||||
| Classification | Pharmaceutical intermediate >> Heterocyclic compound intermediate >> Pyrimidine compound |
|---|---|
| Name | 5,8-Dimethoxy-[1,2,4]triazolo[1,5-c]pyrimidin-2-amine |
| Synonyms | 2-Amino-5,8-dimethoxy-[1,2,4]triazolo[1,5-c]pyrimidine |
| Molecular Structure | ![]() |
| Molecular Formula | C7H9N5O2 |
| Molecular Weight | 195.18 |
| CAS Registry Number | 219715-62-5 |
| EC Number | 875-177-8 |
| SMILES | COC1=CN=C(N2C1=NC(=N2)N)OC |
| Density | 1.61 |
|---|---|
| Melting point | 201-203 ºC |
| Hazard Symbols |
| ||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hazard Statements | H302-H315-H319-H332-H335 Details | ||||||||||||||||||||||||
| Precautionary Statements | P261-P280-P305+P351+P338 Details | ||||||||||||||||||||||||
| Hazard Classification | |||||||||||||||||||||||||
| |||||||||||||||||||||||||
| SDS | Available | ||||||||||||||||||||||||
|
5,8-Dimethoxy-[1,2,4]triazolo[1,5-c]pyrimidin-2-amine is a heterocyclic compound known for its unique structural and pharmacological properties. This substance, often abbreviated for convenience, has attracted much attention for its potential applications in medicinal chemistry, particularly in the development of therapeutic agents. The discovery of 5,8-dimethoxy-[1,2,4]triazolo[1,5-c]pyrimidin-2-amine stemmed from a broader exploration of triazolopyrimidines, a class of compounds that combine structural features of triazole and pyrimidine. These hybrid structures have received a great deal of attention from chemists for their potential biological activities. The synthesis of 5,8-dimethoxy-[1,2,4]triazolo[1,5-c]pyrimidin-2-amine involves the reaction of appropriate precursors under specific conditions to form this uniquely substituted triazolopyrimidine. One of the most promising applications of this compound lies in its potential as a therapeutic agent. Preliminary studies have shown that 5,8-dimethoxy-[1,2,4]triazolo[1,5-c]pyrimidin-2-amine exhibits significant pharmacological activity, including anti-inflammatory, antimicrobial, and anticancer properties. Its anti-inflammatory potential is particularly noteworthy, as inflammation is a common underlying factor in many chronic diseases. By inhibiting key enzymes and pathways involved in inflammatory responses, this compound could help manage diseases such as arthritis, asthma, and inflammatory bowel disease. In the field of antimicrobial therapy, 5,8-dimethoxy-[1,2,4]triazolo[1,5-c]pyrimidin-2-amine has shown efficacy against a variety of bacterial and fungal strains. This is critical in the context of rising antibiotic resistance, as new antimicrobial agents are urgently needed to combat resistant pathogens. The compound's ability to interfere with microbial growth and replication makes it a potential candidate for further development into a new antibiotic or antifungal agent. The anticancer potential of 5,8-dimethoxy-[1,2,4]triazolo[1,5-c]pyrimidin-2-amine is another area of active research. Early studies have shown that the compound can induce apoptosis (programmed cell death) in cancer cells, a desirable effect for cancer treatment. By targeting a specific molecular pathway that is often dysregulated in cancer, this compound could offer a new approach to treating various types of cancer, including those that are resistant to traditional therapies. In addition to direct therapeutic applications, 5,8-dimethoxy-[1,2,4]triazolo[1,5-c]pyrimidin-2-amine is also of great value in the field of medicinal chemistry as a scaffold for drug development. Its unique structure provides a versatile framework that can be modified to enhance desired pharmacological properties or reduce potential side effects. This makes it an attractive starting point for the synthesis of novel compounds with improved efficacy and safety. In addition to medical applications, 5,8-dimethoxy-[1,2,4]triazolo[1,5-c]pyrimidin-2-amine has applications in agrochemistry. Given its antimicrobial properties, it could be developed into new agrochemicals for protecting crops from bacterial and fungal diseases. This will help achieve more sustainable agricultural practices by reducing reliance on traditional chemical pesticides, which often have adverse effects on the environment. |
| Market Analysis Reports |
| List of Reports Available for 5,8-Dimethoxy-[1,2,4]triazolo[1,5-c]pyrimidin-2-amine |